BMEA · Biomea Fusion
The AI's read
A share-price move alone does not show whether Biomea Fusion's business prospects changed. The article gives no company news or reason for the move.
Biomea Fusion shares rose about 11% after hours. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
A share-price move alone does not show whether Biomea Fusion's business prospects changed. The article gives no company news or reason for the move.
iTonic Holdings shares rose about 10%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
VivoSim Labs shares rose about 7%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
ARS Pharmaceuticals shares rose about 7%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
Tempest Therapeutics shares rose about 6%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
Dare Bioscience shares rose about 5%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
Follow Biomea Fusion (BMEA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BMEA